The Effect of Photoimmunotherapy Followed by Liposomal Daunorubicin in a Mixed Tumor Model: A Demonstration of the Super-Enhanced Permeability and Retention Effect after Photoimmunotherapy
- 1 February 2014
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 13 (2) , 426-432
Abstract
In general, de novo solid tumors are composed of phenotypically and functionally heterogeneous malignant cells. This heterogeneity interferes with the effectiveness of targeted molecular cancer therapies. Even if most of the tumor is killed by a targeted treatment, recurrences are common and can be lethal. In this study, a mixed tumor model, which is predominantly a population of epidermal growth factor receptor (EGFR)-positive A431 cells combined with a smaller population of EGFR-negative Balb3T3/DsRed cells, was established. This mixed tumor was then treated with photoimmunotherapy, a newly developed target-cell–selective cancer therapy using a monoclonal antibody (mAb)–photosensitizer (IR700 fluorescence dye) conjugate and exposure of near-infrared light. Although photoimmunotherapy successfully treated EGFR-positive A431 cells in the mixed tumor, EGFR-negative Balb/DsRed cells were not responsive. However, photoimmunotherapy also induced a large increase in tumor permeability, known as the super-enhanced permeability and retention (SUPR) effect, which allowed a 5-fold increase in the accumulation of a liposomal chemotherapy (DaunoXome) and resulted in more effective therapy than either photoimmunotherapy or liposomal daunorubicin alone. The liposomal daunorubicin, administered 1 hour after EGFR-targeted photoimmunotherapy, was homogeneously distributed, allowing delivery to tiny surviving nests of EGFR-negative Balb3T3/DsRed cells, resulting in prolonged survival of mice. Mol Cancer Ther; 13(2); 426–32. ©2013 AACR.Keywords
This publication has 21 references indexed in Scilit:
- Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of TumorsACS Nano, 2012
- Interstitial Doppler Optical Coherence Tomography as a Local Tumor Necrosis Predictor in Photodynamic Therapy of Prostatic Carcinoma: AnIn vivoStudyCancer Research, 2008
- In vivoDiagnosis of Epidermal Growth Factor Receptor Expression using Molecular Imaging with a Cocktail of Optically Labeled Monoclonal AntibodiesClinical Cancer Research, 2007
- Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neuClinical Cancer Research, 2007
- Interstitial Doppler optical coherence tomography monitors microvascular changes during photodynamic therapy in a Dunning prostate model under varying treatment conditionsJournal of Biomedical Optics, 2007
- Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic ImplicationsClinical Cancer Research, 2006
- Photodynamic therapy: a means to enhanced drug delivery to tumors.2003
- Mechanisms of tumor progression.1986
- Biological Diversity in Metastatic Neoplasms: Origins and ImplicationsScience, 1982
- Metastasis Results from Preexisting Variant Cells Within a Malignant TumorScience, 1977